Cargando…
3-nitroimidazo[1,2-b]pyridazine as a novel scaffold for antiparasitics with sub-nanomolar anti-Giardia lamblia activity
As there is a continuous need for novel anti-infectives, the present study aimed to fuse two modes of action into a novel 3-nitroimidazo[1,2-b]pyridazine scaffold to improve antiparasitic efficacy. For this purpose, we combined known structural elements of phosphodiesterase inhibitors, a target rece...
Autores principales: | Zheng, Yang, Müller, Joachim, Kunz, Stefan, Siderius, Marco, Maes, Louis, Caljon, Guy, Müller, Norbert, Hemphill, Andrew, Sterk, Geert Jan, Leurs, Rob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213561/ https://www.ncbi.nlm.nih.gov/pubmed/35716585 http://dx.doi.org/10.1016/j.ijpddr.2022.05.004 |
Ejemplares similares
-
The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target
por: Kunz, Stefan, et al.
Publicado: (2017) -
Physiological aspects of nitro drug resistance in Giardia lamblia
por: Müller, Joachim, et al.
Publicado: (2018) -
Comparative Pathobiology of the Intestinal Protozoan Parasites Giardia lamblia, Entamoeba histolytica, and Cryptosporidium parvum
por: Hemphill, Andrew, et al.
Publicado: (2019) -
Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis
por: Jarrad, A.M., et al.
Publicado: (2016) -
Nitroreductases of bacterial origin in Giardia lamblia: Potential role in detoxification of xenobiotics
por: Müller, Joachim, et al.
Publicado: (2019)